Long-term safety and efficacy of agalsidase beta in Japanese patients with Fabry disease: aggregate data from two post-authorization safety studies
Keyword(s):
Keyword(s):
2018 ◽
Vol 19
(4)
◽
pp. 327-336
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 25
(5)
◽
pp. 665-671
◽
2016 ◽
Vol 30
(11)
◽
pp. 1957-1960
◽
Keyword(s):
Keyword(s):
2004 ◽
Vol 75
(1)
◽
pp. 65-74
◽
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A458.1-A458
◽